TG THERAPEUTICS, INC. - COM (TGTX)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
88 M
Holdings value Q1 2024
$1.34 B
Value change Q1 2024
-$24.6 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
224
Number of buys Q1 2024
110
Number of sells Q1 2024
-103
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.002%
CUSIP
88322Q108
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 88 M $1.34 B -$24.6 M $15.21 224
2023 Q4 88.5 M $1.51 B +$83.7 M $17.08 228
2023 Q3 88.3 M $738 M -$269 M $8.36 225
2023 Q2 86.8 M $2.16 B -$103 M $24.84 242
2023 Q1 93.5 M $1.41 B +$45.7 M $15.04 205
2022 Q4 93.1 M $1.1 B -$28.4 M $11.83 190
2022 Q3 97.2 M $575 M -$20.7 M $5.92 164
2022 Q2 88.6 M $376 M +$45.4 M $4.25 153
2022 Q1 99.5 M $947 M -$98.4 M $9.51 168
2021 Q4 99.5 M $1.89 B +$31.2 M $19.00 182
2021 Q3 96.2 M $3.2 B -$41.7 M $33.28 213
2021 Q2 95.5 M $3.7 B -$96.8 M $38.79 229
2021 Q1 98.8 M $4.76 B -$16.9 M $48.20 233
2020 Q4 98.3 M $5.11 B +$668 M $52.02 246
2020 Q3 86.3 M $2.31 B +$117 M $26.76 177
2020 Q2 81.1 M $1.58 B +$377 M $19.48 168
2020 Q1 63.7 M $627 M +$63.3 M $9.84 135
2019 Q4 58.2 M $646 M +$108 M $11.10 133
2019 Q3 48.1 M $270 M -$15.5 M $5.62 110
2019 Q2 50.2 M $434 M +$22.6 M $8.65 116
2019 Q1 48 M $386 M +$34 M $8.04 107
2018 Q4 48.2 M $197 M -$2.13 M $4.10 105
2018 Q3 47.6 M $267 M +$32.2 M $5.60 120
2018 Q2 40.4 M $532 M +$24.3 M $13.15 119
2018 Q1 38.6 M $548 M +$48.8 M $14.20 118
2017 Q4 35.8 M $293 M -$8.67 M $8.20 102
2017 Q3 35.6 M $422 M +$16.1 M $11.85 97
2017 Q2 34.3 M $345 M +$34.2 M $10.05 101
2017 Q1 30.8 M $359 M +$141 M $11.65 95
2016 Q4 21.7 M $101 M -$33.4 M $4.65 84
2016 Q3 26.9 M $208 M -$5.61 M $7.74 67
2016 Q2 27.9 M $169 M -$14.6 M $6.06 81
2016 Q1 29.5 M $252 M +$21.7 M $8.52 74
2015 Q4 26.8 M $320 M -$6.21 M $11.93 83
2015 Q3 24.9 M $251 M +$34.1 M $10.08 80
2015 Q2 23.5 M $389 M +$18.8 M $16.59 87
2015 Q1 18.3 M $283 M +$45.7 M $15.48 77
2014 Q4 15.3 M $242 M +$26.3 M $15.84 75
2014 Q3 15.5 M $165 M +$5.22 M $10.67 64
2014 Q2 13 M $122 M +$12.4 M $9.39 64
2014 Q1 11.6 M $80.3 M +$31.8 M $6.90 48